12 results
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Antiarrhythmic Drugs ... Antiarrhythmic #Drugs ... #Cardiology #Table ... #Effects
Clinical features of focal cortical brain lesions in a right-handed individual

Frontal, either:  
Intellectual impairment, 
Personality
Clinical features ... Limb apraxia Occipital ... Visual field defects ... Visuospatial defects ... Localization #Symptoms #Signs
Selective Serotonin Reuptake Inhibitors: Mechanisms and Side Effects
 • Serotonin Syndrome:
   - Autonomic Hyperactivity:
Serotonin Reuptake Inhibitors ... Mechanisms and Side Effects ... SSRIs #Serotonin #Inhibitors ... Pathophysiology #Pharmacology ... Psychiatry #Diagnosis #Signs
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Agents Subclass, Drug ... Mechanism of Action, Effects ... , Clinical Applications ... #Medications #Pharmacology ... #summary #table
Effects of Strokes by Location - Anterior vs Posterior Localization

Anterior Circulation 
 - MCA 
 -
Effects of Strokes ... Territory #Symptoms #Signs ... #Localization #Effects ... Neurology #Diagnosis #Table ... Comprehensive Review in Clinical
Serotonin-Norepinephrine Reuptake Inhibitors(SNRIs): Mechanisms and Side Effects

Withdrawal: Dizziness, Diarrhea, Insomnia, Nausea, Vomiting
Serotonin Syndrome - Potentially Life
Serotonin-Norepinephrine Reuptake Inhibitors ... Mechanisms and Side Effects ... SerotoninNorepinephrine #Inhibitors ... Pathophysiology #Pharmacology ... Psychiatry #Diagnosis #Signs
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Clinically Significant ... Cardiovascular Drug-Drug ... Angiotensin-Converting Enzyme Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Dosing: 250 mcg tablet ... won’t have any clinical ... effect. ... #Indications #Pharmacology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Paraneoplastic effects ... Clinical Picture ... test - Cogan sign ... - Peek sign ... precipitated by: Drugs
Transverse lines of the fingernails. (A) Beau’s lines (arrows) of the thumbnail. (B) Mees’ lines (arrowheads)
conditions or the effects ... of a toxin or drug ... are a typical sign ... FingerNails #Ridges #Clinical